Keywords: CEST / APT / NOE, CEST & MT
Motivation: Amide protein transfer-weighted (APTw) MRI has been validated to accurately detect recurrent malignant gliomas across different studies. However, APTw image interpretation is time consuming and requires professional knowledge.
Goal(s): Our goal was to develop a reliable, automated imaging diagnostic tool to assess malignant glioma response to therapies are urgently needed.
Approach: We developed and verified a unified CNN-based deep-learning framework for both tumor segmentation and tumor progression assessment by adding APTw MRI data to structural MR images as model input.
Results: The use of APTw images can improve not only diagnostic accuracy but also segmentation performance to structural MRIs.
Impact: The proposed deep-learning method could be a highly efficient solution that could help clinical experts to make precise diagnoses for patients with post-treatment gliomas.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords